| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.23 | 0.2 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.24 | 0.2 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |